GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) » Definitions » EV-to-EBIT

Hangzhou Minsheng Healthcare Co (SZSE:301507) EV-to-EBIT : 39.31 (As of May. 13, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou Minsheng Healthcare Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Hangzhou Minsheng Healthcare Co's Enterprise Value is ¥3,992.0 Mil. Hangzhou Minsheng Healthcare Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥101.6 Mil. Therefore, Hangzhou Minsheng Healthcare Co's EV-to-EBIT for today is 39.31.

The historical rank and industry rank for Hangzhou Minsheng Healthcare Co's EV-to-EBIT or its related term are showing as below:

SZSE:301507' s EV-to-EBIT Range Over the Past 10 Years
Min: 30.69   Med: 43.21   Max: 69.78
Current: 39.31

During the past 6 years, the highest EV-to-EBIT of Hangzhou Minsheng Healthcare Co was 69.78. The lowest was 30.69. And the median was 43.21.

SZSE:301507's EV-to-EBIT is ranked worse than
81.41% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.91 vs SZSE:301507: 39.31

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Hangzhou Minsheng Healthcare Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥3,628.3 Mil. Hangzhou Minsheng Healthcare Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥101.6 Mil. Hangzhou Minsheng Healthcare Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 2.80%.


Hangzhou Minsheng Healthcare Co EV-to-EBIT Historical Data

The historical data trend for Hangzhou Minsheng Healthcare Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Minsheng Healthcare Co EV-to-EBIT Chart

Hangzhou Minsheng Healthcare Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - - - 53.04

Hangzhou Minsheng Healthcare Co Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 70.57 53.04 35.73

Competitive Comparison of Hangzhou Minsheng Healthcare Co's EV-to-EBIT

For the Drug Manufacturers - General subindustry, Hangzhou Minsheng Healthcare Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Minsheng Healthcare Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou Minsheng Healthcare Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hangzhou Minsheng Healthcare Co's EV-to-EBIT falls into.



Hangzhou Minsheng Healthcare Co EV-to-EBIT Calculation

Hangzhou Minsheng Healthcare Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3992.035/101.553
=39.31

Hangzhou Minsheng Healthcare Co's current Enterprise Value is ¥3,992.0 Mil.
Hangzhou Minsheng Healthcare Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥101.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Minsheng Healthcare Co  (SZSE:301507) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Hangzhou Minsheng Healthcare Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=101.553/3628.34514
=2.80 %

Hangzhou Minsheng Healthcare Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥3,628.3 Mil.
Hangzhou Minsheng Healthcare Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥101.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Minsheng Healthcare Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Hangzhou Minsheng Healthcare Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Minsheng Healthcare Co (SZSE:301507) Business Description

Traded in Other Exchanges
N/A
Address
No. 101, Xintian Road, Donghu Street, Linping, Zhejiang, Hangzhou, CHN, 311100
Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).

Hangzhou Minsheng Healthcare Co (SZSE:301507) Headlines

No Headlines